Last reviewed · How we verify
Airtal® film-coated tablet 100 mg — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Airtal® film-coated tablet 100 mg (Airtal® film-coated tablet 100 mg) — Pharmtechnology LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Airtal® film-coated tablet 100 mg TARGET | Airtal® film-coated tablet 100 mg | Pharmtechnology LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Airtal® film-coated tablet 100 mg CI watch — RSS
- Airtal® film-coated tablet 100 mg CI watch — Atom
- Airtal® film-coated tablet 100 mg CI watch — JSON
- Airtal® film-coated tablet 100 mg alone — RSS
Cite this brief
Drug Landscape (2026). Airtal® film-coated tablet 100 mg — Competitive Intelligence Brief. https://druglandscape.com/ci/airtal-film-coated-tablet-100-mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab